DAVID ALTSHULER - 10 Feb 2023 Form 4 Insider Report for VERTEX PHARMACEUTICALS INC / MA (VRTX)

Signature
/s/ Christiana Stevenson, Attorney-in-Fact
Issuer symbol
VRTX
Transactions as of
10 Feb 2023
Net transactions value
-$4,239,380
Form type
4
Filing time
14 Feb 2023, 15:49:25 UTC
Previous filing
08 Feb 2023
Next filing
16 Feb 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VRTX Common Stock Tax liability $1,018,676 -3,461 -5% $294.33 65,184 10 Feb 2023 Direct
transaction VRTX Common Stock Tax liability $1,786,577 -5,990 -9.2% $298.26 59,194 13 Feb 2023 Direct
transaction VRTX Common Stock Sale $72,628 -245 -0.41% $296.44 58,949 13 Feb 2023 Direct F1, F2, F3
transaction VRTX Common Stock Sale $644,695 -2,160 -3.7% $298.47 56,789 13 Feb 2023 Direct F1, F2, F4
transaction VRTX Common Stock Sale $566,688 -1,893 -3.3% $299.36 54,896 13 Feb 2023 Direct F1, F2, F5
transaction VRTX Common Stock Sale $150,115 -500 -0.91% $300.23 54,396 13 Feb 2023 Direct F1, F2, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Transaction made pursuant to Dr. Altshuler's company approved trading plan under Rule 10b5-1.
F2 Dr. Altshuler undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
F3 Open market sales reported on this line occurred at a weighted average price of $296.44 (range $295.84 to $296.57).
F4 Open market sales reported on this line occurred at a weighted average price of $298.47 (range $297.85 to $298.82).
F5 Open market sales reported on this line occurred at a weighted average price of $299.36 (range $298.86 to $299.83).
F6 Open market sales reported on this line occurred at a weighted average price of $300.23 (range $299.96 to $300.63).